Features of whey protein concentrate supplementation in children with rapidly progressive HIV infection

Y F Moreno1, V C Sgarbieri, M N da Silva

  • 1Center for Investigation in Pediatrics (CIPED), Pediatrics Department, and Food and Nutrition Department, Food Engineering School, State University of Campinas, São Paulo, Brazil.

Insights

Whey protein concentrate supplementation significantly increased erythrocyte glutathione levels in children with rapidly progressive AIDS. This intervention may also reduce co-infections in pediatric HIV patients.

Area of Science:

  • Nutrition Science
  • Immunology
  • Pediatric Infectious Diseases

Background:

  • HIV infection is linked to reduced glutathione (GSH) levels.
  • Oral whey protein supplementation has previously increased GSH in HIV-infected adults.

Purpose of the Study:

  • To investigate the effects of whey protein concentrate supplementation on glutathione levels and immune markers in vertically HIV-infected children.
  • To assess the impact of whey protein on co-infections in this pediatric population.

Main Methods:

  • Prospective, double-blind, placebo-controlled trial over 4 months.
  • 18 vertically HIV-infected children received whey protein, maltodextrin (placebo), or no supplementation.
  • Evaluated erythrocyte glutathione, T lymphocyte counts (CD4+, CD8+), and co-infections.

Main Results:

  • Significant median increase in erythrocyte glutathione levels (16.14 mg/dl, p = 0.018) in the whey protein group.
  • Non-significant increase in the TCD4/CD8 lymphocyte ratio.
  • Observed a lower occurrence of associated co-infections in the supplemented group.

Conclusions:

  • Whey protein concentrate supplementation can stimulate glutathione synthesis in HIV-infected children.
  • This supplementation may potentially decrease the incidence of co-infections in pediatric AIDS.
  • Highlights the role of nutritional interventions in managing pediatric HIV.

Related Concept Videos

Immunodeficiency Diseases01:25

Immunodeficiency Diseases

Immunodeficiency disorders are conditions in which the immune system's ability to fight infectious disease and cancer is compromised or entirely absent. The immune system comprises a complex network of cells, tissues, and organs that work together to protect the body from potentially harmful invaders. When this system is deficient or not functioning properly, it leaves the body susceptible to infections, diseases, or other complications.
There are three main causes of immunodeficiency disorders...
Overview of Protein Metabolism01:21

Overview of Protein Metabolism

Proteins are broken down into amino acids during digestion. Unlike fats and carbohydrates, which are stored for later use, proteins are not. Instead, amino acids are either used to produce ATP through oxidation or contribute to the creation of new proteins for the growth and repair of the body. Any surplus amino acids from the diet are converted into glucose or triglycerides rather than excreted.
Amino acids play various roles in the body once they are absorbed into cells. They are restructured...
Protein Absorption01:12

Protein Absorption

Proteins in the gastrointestinal tract typically come from food, but they can also originate from disintegrated cells or secreted enzymes. In the stomach, the enzyme pepsin breaks down these proteins into polypeptides. The fragments then move into the duodenum as a semi-fluid mass called chyme. Pancreatic proteases, such as trypsin and chymotrypsin, and intestinal brush border enzymes like carboxypeptidases further dismantle the polypeptides into tripeptides, dipeptides, and free amino acids.
Pharmacokinetics in Pediatric Patients: Drug Metabolism01:24

Pharmacokinetics in Pediatric Patients: Drug Metabolism

In pediatric care, understanding the nuances of hepatic drug metabolism is crucial, as it significantly differs from that of adults. This divergence is primarily due to the developmental stage of drug-metabolizing enzymes, which affects how medications are processed in the body. In neonates, for instance, the activity of Phase I enzymes—critical for the initial breakdown of drugs—is markedly reduced, functioning at just 20–40% of the levels seen in adults. This reduction poses a challenge in...
Pharmacokinetics in Pediatric Patients: Drug Excretion01:26

Pharmacokinetics in Pediatric Patients: Drug Excretion

In pediatric medicine, understanding the renal function and drug elimination nuances is crucial for administering safe and effective treatments. Newborns, in particular, display markedly slower renal functions than adults, profoundly affecting how drugs are cleared from their bodies. This slower drug clearance requires clinicians to extend the dosing intervals for many medications to prevent drug accumulation and toxicity while ensuring therapeutic efficacy.One key area where these adjustments...
Cryptococcal Meningitis01:27

Cryptococcal Meningitis

Cryptococcal meningitis is a life-threatening opportunistic infection predominantly associated with HIV/AIDS, accounting for over 100,000 deaths annually worldwide. However, it also affects individuals with other forms of immunosuppression, including those undergoing immunosuppressive therapy, organ transplant recipients, patients with innate immunodeficiencies, and individuals with hematological disorders. The infection is caused mainly by Cryptococcus neoformans and Cryptococcus gattii,...